Sabri O - Search Results

1

Brain PET and functional MRI: why simultaneously using hybrid PET/MR systems?

Cecchin D, Palombit A, Castellaro M, Silvestri E, Bui F, Barthel H, Sabri O, Corbetta M, Bertoldo A. Cecchin D, et al. Among authors: sabri o. Q J Nucl Med Mol Imaging. 2017 Dec;61(4):345-359. doi: 10.23736/S1824-4785.17.03008-4. Epub 2017 Jul 27. Q J Nucl Med Mol Imaging. 2017. PMID: 28750494 Review.

2

Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET.

Cremerius U, Bares R, Weis J, Sabri O, Mull M, Schröder JM, Gilsbach JM, Buell U. Cremerius U, et al. Among authors: sabri o. J Nucl Med. 1997 Jan;38(1):26-30. J Nucl Med. 1997. PMID: 8998144 Free article.

3

Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases.

Zimny M, Bares R, Fass J, Adam G, Cremerius U, Dohmen B, Klever P, Sabri O, Schumpelick V, Buell U. Zimny M, et al. Among authors: sabri o. Eur J Nucl Med. 1997 Jun;24(6):678-82. doi: 10.1007/BF00841409. Eur J Nucl Med. 1997. PMID: 9169578

4

Correlation of neuropsychological, morphological and functional (regional cerebral blood flow and glucose utilization) findings in cerebral microangiopathy.

Sabri O, Hellwig D, Schreckenberger M, Cremerius U, Schneider R, Kaiser HJ, Doherty C, Mull M, Ringelstein EB, Buell U. Sabri O, et al. J Nucl Med. 1998 Jan;39(1):147-54. J Nucl Med. 1998. PMID: 9443754 Free article.

5

FDG PET for detection and therapy control of metastatic germ cell tumor.

Cremerius U, Effert PJ, Adam G, Sabri O, Zimmy M, Wagenknecht G, Jakse G, Buell U. Cremerius U, et al. Among authors: sabri o. J Nucl Med. 1998 May;39(5):815-22. J Nucl Med. 1998. PMID: 9591582 Free article.

6

Cerebral interregional correlations of associative language processing: a positron emission tomography activation study using fluorine-18 fluorodeoxyglucose.

Schreckenberger M, Gouzoulis-Mayfrank E, Sabri O, Arning C, Schulz G, Tuttass T, Wagenknecht G, Kaiser HJ, Sass H, Buell U. Schreckenberger M, et al. Among authors: sabri o. Eur J Nucl Med. 1998 Nov;25(11):1511-9. doi: 10.1007/s002590050329. Eur J Nucl Med. 1998. PMID: 9799347 Clinical Trial.

7

"Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET study.

Schreckenberger M, Gouzoulis-Mayfrank E, Sabri O, Arning C, Zimny M, Zeggel T, Wagenknecht G, Kaiser HJ, Sass H, Buell U. Schreckenberger M, et al. Among authors: sabri o. Eur J Nucl Med. 1999 Dec;26(12):1572-9. doi: 10.1007/s002590050497. Eur J Nucl Med. 1999. PMID: 10638409 Clinical Trial.

8

Comparison of visual and ROI-based brain tumour grading using 18F-FDG PET: ROC analyses.

Meyer PT, Schreckenberger M, Spetzger U, Meyer GF, Sabri O, Setani KS, Zeggel T, Buell U. Meyer PT, et al. Among authors: sabri o. Eur J Nucl Med. 2001 Feb;28(2):165-74. doi: 10.1007/s002590000428. Eur J Nucl Med. 2001. PMID: 11303886

9

Analysis of FDG uptake with hybrid PET using standardised uptake values.

Zimny M, Kaiser HJ, Wildberger J, Nowak B, Cremerius U, Sabri O, Buell U. Zimny M, et al. Among authors: sabri o. Eur J Nucl Med. 2001 May;28(5):586-92. doi: 10.1007/s002590100483. Eur J Nucl Med. 2001. PMID: 11383863

10

Localisation of motor areas in brain tumour patients: a comparison of preoperative [18F]FDG-PET and intraoperative cortical electrostimulation.

Schreckenberger M, Spetzger U, Sabri O, Meyer PT, Zeggel T, Zimny M, Gilsbach J, Buell U. Schreckenberger M, et al. Among authors: sabri o. Eur J Nucl Med. 2001 Sep;28(9):1394-403. doi: 10.1007/s002590100582. Eur J Nucl Med. 2001. PMID: 11585300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters